Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-14

Clinical Trial Update: Testopel ® vs. Generic Testosterone Pellets. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Testopel with generic testosterone pellets for hypogonadism has completed, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Generic testosterone pellets (testosterone pellet)
  • TESTOPEL (TESTOSTERONE)

Snippet

Sponsor: University of Miami | Conditions: Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2023-08-14